Nimble Diagnostics
PrivateLast Round
Series A
Apr 1, 2025
Total Funding Raised
$3.71M
Company Overview
Nimble Diagnostics is a medical technology company developing a non-invasive, microwave-based device to monitor patients with implanted stents.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nimble Diagnostics Comps
Public and private peers based on sector, stage, and business model.
Nimble Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2025 | ||||
| Grant | Oct 31, 2023 | ||||
| Seed | Jan 15, 2023 |
Nimble Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Grow Venture Partners | Seed |
| Namarel Ventures | Seed |
| Inveniam Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
$14M round completed.
- Oct 31, 2023
Secured $2.63M from the European Innovation Council
Nimble Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nimble Diagnostics's valuation, stock price, and market status.
